Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00478465
First received: May 23, 2007
Last updated: August 29, 2007
Last verified: August 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2007
  Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):